Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Change in Receivables (2019 - 2023)

Historic Change in Receivables for ADC Therapeutics (ADCT) over the last 5 years, with Q4 2023 value amounting to $4.0 million.

  • ADC Therapeutics' Change in Receivables fell 9064.71% to $4.0 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$47.8 million, marking a year-over-year decrease of 21177.93%. This contributed to the annual value of -$4.8 million for FY2024, which is 9001.65% up from last year.
  • According to the latest figures from Q4 2023, ADC Therapeutics' Change in Receivables is $4.0 million, which was down 9064.71% from -$2.7 million recorded in Q3 2023.
  • In the past 5 years, ADC Therapeutics' Change in Receivables registered a high of $42.7 million during Q4 2022, and its lowest value of -$48.9 million during Q1 2023.
  • Moreover, its 5-year median value for Change in Receivables was -$1539.5 (2020), whereas its average is -$361943.4.
  • As far as peak fluctuations go, ADC Therapeutics' Change in Receivables soared by 29856434.86% in 2022, and later plummeted by 141097709.17% in 2023.
  • ADC Therapeutics' Change in Receivables (Quarter) stood at $150.0 in 2019, then plummeted by 766.67% to -$1000.0 in 2020, then crashed by 1332.2% to -$14322.0 in 2021, then soared by 298564.35% to $42.7 million in 2022, then tumbled by 90.65% to $4.0 million in 2023.
  • Its Change in Receivables was $4.0 million in Q4 2023, compared to -$2.7 million in Q3 2023 and -$188000.0 in Q2 2023.